E.M. Huber
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Glycosylation and Glycoproteins Research
- Protein Degradation and Inhibitors
Papers in
-
- Ubiquitin and proteasome pathways 19
- Glycosylation and Glycoproteins Research 11
- Fungal and yeast genetics research 4
- Genomics, phytochemicals, and oxidative stress 4
- RNA and protein synthesis mechanisms 3
- Oncology 15
- Peptidase Inhibition and Analysis 15
- Co-authors
- M. Groll (34 shared papers)Wolfgang Heinemeyer (9 shared papers)Marcus Groettrup (3 shared papers)Ricarda Schwab (2 shared papers)Christopher J. Kirk (2 shared papers)Michael Basler (2 shared papers)Axel A. Brakhage (9 shared papers)Gerjan de Bruin (5 shared papers)
- Journals
- Angewandte Chemie International Edition (7 papers)Structure (6 papers)Journal of Medicinal Chemistry (3 papers)ACS Chemical Biology (2 papers)Molecular Immunology (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
E.M. Huber
43 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 110
- Oncology 503
- Molecular Biology 1.2k
- Cell Biology 170
- Immunology 157
- Hematology 82
Countries citing papers authored by E.M. Huber
This map shows the geographic impact of E.M. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M. Huber more than expected).
Fields of papers citing papers by E.M. Huber
This network shows the impact of papers produced by E.M. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M. Huber. The network helps show where E.M. Huber may publish in the future.
Co-authors
The 25 scholars most cited alongside E.M. Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 411 | |
| 2 | 2012 | 154 | |
| 3 | 1999 | 154 | |
| 4 | 2016 | 98 | |
| 5 | 2014 | 88 | |
| 6 | 2015 | 58 | |
| 7 | 2012 | 49 | |
| 8 | 2014 | 49 | |
| 9 | 2017 | 47 | |
| 10 | 2015 | 41 | |
| 11 | 2016 | 41 | |
| 12 | 1998 | 34 | |
| 13 | 2019 | 31 | |
| 14 | 2019 | 30 | |
| 15 | 2016 | 30 | |
| 16 | 2017 | 30 | |
| 17 | 2009 | 29 | |
| 18 | 2012 | 27 | |
| 19 | 2022 | 25 | |
| 20 | 2015 | 24 |
About E.M. Huber
E.M. Huber is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cell Biology and Immunology, having authored 45 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (19 papers), Peptidase Inhibition and Analysis (15 papers), Glycosylation and Glycoproteins Research (11 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Fungal and yeast genetics research (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Click Chemistry and Applications (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Oncology (503 citations), Molecular Biology (1.2k citations), Cell Biology (170 citations), Immunology (157 citations) and Hematology (82 citations). E.M. Huber has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include M. Groll, Wolfgang Heinemeyer, Marcus Groettrup, Ricarda Schwab, Christopher J. Kirk, Michael Basler, Axel A. Brakhage, Gerjan de Bruin, Herman S. Overkleeft and Daniel H. Scharf. Their work appears in journals such as Angewandte Chemie International Edition, Structure, Journal of Medicinal Chemistry, ACS Chemical Biology and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.